Effects of the Myofascial Arm Pull With and Without Active Release Technique in Adhesive Capsulitis

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Oct 30, 2023

Keywords

ClinConnect Summary

This clinical trial is studying two different treatments for adhesive capsulitis, also known as frozen shoulder. The goal is to see how effective a technique called the "myofascial arm pull" is, both on its own and when combined with another method called "active release technique." Researchers want to find out how these treatments can help reduce pain, improve the ability to move the shoulder, and decrease disability caused by the condition.

To participate in this trial, you need to be between 35 and 60 years old and have a diagnosis of adhesive capsulitis in its freezing stage, with at least 50% loss of shoulder movement. Unfortunately, people who have had recent shoulder surgery, certain other shoulder conditions, or specific health issues, like cancer, cannot take part. If you join, you can expect to receive one of the treatments and share your experiences regarding pain and movement, which will help researchers understand the best ways to help people with this condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Both Male and Female; mean age (35-60).
• • Case diagnosed with adhesive capsulitis, both primary and secondary origin.
• • Freezing stage of adhesive capsulitis.
• • Those with at least a 50% reduction in the range of motion (ROM).
• Exclusion Criteria:
• • History of shoulder surgery or manipulation under anesthesia, local corticosteroid injection administration to the affected shoulder within the last 3 months.
• • Neurological deficit affecting the shoulder functioning during daily activities.
• • Pathology of the shoulder joint other than adhesive capsulitis.
• • Pain or disorder of the cervical spine, elbow, wrist or hand.
• • Patients diagnosed with cancer